NBC News: New Alzheimer's drug comes with steep price tag
UC expert says doctors, patients will have to consider financial burden when making decision
Leqembi, a newly approved drug for use in people with mild cognitive impairment or early Alzheimer's disease, comes with a price of $26,500 a year.
Experts say the high price, along with Medicare only covering the drug for patients enrolled in a clinical trial, will mean only a limited number of patients will be able to get the drug when it becomes available.
The University of Cincinnati's Alberto Espay, MD, professor of neurology in the UC College of Medicine, director and endowed chair of the James J. and Joan A. Gardner Family Center for Parkinson’s Disease and Movement Disorders at the UC Gardner Neuroscience Institute and a UC Health physician, told NBC News the price of the drug is "very unfortunate."
Espay said doctors will need to include the financial burden as a possible risk of the drug when discussing its potential benefits of modestly slowing the disease. He is a proponent of an alternative theory that it is the loss of the normal amyloid protein, rather than the build-up of the abnormal amyloid plaques, that leads to degeneration.
Previously, Espay noted the benefits of Leqembi may stem from the fact that it increases levels of the normal protein in the brain in addition to its primary aim of removing plaques.
Read the NBC News article on the price of Leqembi.
Read the NBC News article featuring Espay about unanswered questions about Leqembi.
Espay also discussed Leqembi and the state of Alzheimer's research on WVXU's Cincinnati Edition. Listen to the Cincinnati Edition segment.
Read more about Espay's research and alternative Alzheimer's hypothesis.
Featured photo at top courtesy of Unsplash.
Related Stories
WLWT: UC hosts RESET epilepsy trial
May 3, 2023
WLWT spoke with the University of Cincinnati's Brandon Foreman about a clinical trial testing a new treatment for status epilepticus, the most severe and deadly form of epilepsy.
Five to Thrive Live features UC's Sengupta
October 14, 2022
The University of Cincinnati's Soma Sengupta, MD, PhD, joined the Five to Thrive Live podcast to discuss "Humanizing Brain Tumors."
Spectrum News: Mobile stroke unit getting treatment to patients faster
September 15, 2023
Spectrum News recently highlighted the work of the UC Health mobile stroke unit that brings stroke care to patients faster and helped treat local patient Don Mundy.
Healio: Sleep, diet among keys to preserving cognitive function during cancer survivorship
September 25, 2023
The University of Cincinnati's Rhonna Shatz, DO, spoke with Healio about cognitive function during cancer survivorship.
WVXU: UC study tests tongue exercises to improve swallowing function after stroke
January 11, 2024
WVXU highlighted a new trial at the University of Cincinnati that will test an at-home tongue endurance exercise to improve patients’ swallowing function after a stroke.
iHeart Cinci Podcast: UC expert discusses traumatic brain injuries
April 1, 2024
The University of Cincinnati's Brandon Foreman joined the iHeart Cinci Podcast to discuss traumatic brain injuries, including signs to look for and how to discuss the topic with your doctor.
55KRC: UC leads way in implementing new stroke treatment regionally
November 8, 2022
The University of Cincinnati's Stacie Demel, DO, PhD, joined the Simply Medicine podcast to discuss TNK, a new treatment for acute ischemic stroke now available to patients across Greater Cincinnati.
U.S. News and World Report: Signs that it's time for memory care
November 3, 2022
The University of Cincinnati's Rhonna Shatz was featured in a U.S. News and World Report article on signs that a patient with dementia may need a higher level of care.
Local media highlight Stroke Awareness Month
May 18, 2022
The University of Cincinnati's Eva Mistry and Pooja Khatri were recent guests on local news programs to discuss National Stroke Awareness Month.
55KRC: UC studies sickle cell's effect on neurological conditions
July 25, 2022
The University of Cincinnati's Hyacinth I. Hyacinth was a guest on 55KRC's Simply Medicine program to discuss his research into sickle cell disease, stroke and cognitive impairment.